Kolexia
Lledo Gerard Gastro-entérologie
Lledo Gerard
Gastro-entérologie
Centre Léon-Bérard
Lyon, France
86 Activités
134 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du rectum Adénocarcinome Métastase tumorale Tumeurs du côlon Tumeurs de l'oesophage Tumeurs du foie Carcinomes Cholangiocarcinome

Collaborateurs

Voir plus
Artru Pascal
Artru Pascal
Hopital Prive De L'est Lyonnais (hpel), Saint-Priest, France
Desrame Jerome
Desrame Jerome
Clinique Du Parc Lyon, Lyon, France
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France
Mammar Vincent
Mammar Vincent
Selarl Orlam, Mâcon, France

Industries

Voir plus
CanceroDigest
46 collaboration(s)
Dernière en 2023
Pierre Fabre
5 collaboration(s)
Dernière en 2022
Mylan Medical
2 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
BACAP-2: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Essai Clinique (CHU Toulouse)   20 novembre 2023
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   30 juin 2023
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer: Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo
Essai Clinique (Unicancer)   15 février 2021
BRAF V600E-mutant colorectal cancers: Where are we?.
Bulletin du cancer   14 juillet 2020
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   08 juin 2019
FOXAGAST: Phase II Study of NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma
Essai Clinique (Celgene)   26 février 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
International journal of oncology   01 février 2019
Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study.
Cancer management and research   24 septembre 2018
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology   29 mai 2018
Impact of primary tumor sidedness on erlotinib efficacy in patients with metastatic colorectal cancer treated with bevacizumab maintenance: Results from the DREAM phase III trial.
2018 Gastrointestinal Cancers Symposium   26 février 2018